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Background: Randomised controlled trials are widely established as the best method for testing health interventions
whilst minimising bias. However, recruitment and subsequent retention of children and adolescents in healthcare trials
is challenging. Participant information sheets are often lengthy and difficult to read and understand. Presenting key
information using multimedia may help to overcome these limitations and better support young people and their
parents in deciding whether to participate in a clinical trial.
Methods: The TRECA (TRials Engagement in Children and Adolescents) study has two phases. The first phase involves
a qualitative study with children and adolescents and their parents to inform the development of multimedia
information resources and iterative user testing to refine the resources. The second phase will embed the use of the
multimedia information resources into six host trials in the United Kingdom. Patients and parents approached
to participate in the host trials will be randomly allocated to either use the multimedia information resource
in conjunction with standard participant information sheets, the multimedia information resource alone, or the
standard participant information sheets alone. The primary outcome will be the effect of the multimedia information
resources on recruitment into trials. Other outcomes measured include the effect of multimedia information resources
on retention of participants into the host trials and the impact on family members’ decision-making processes, when
compared to standard participant information sheets alone.
Discussion: This study will inform whether multimedia information resources, when developed using participatory
design principles, are able to increase recruitment and retention of children and adolescents into trials. There is also the
potential for patients to make better informed decisions through the use of multimedia information resources. The
multimedia information resources also have the potential to assist with providing information on other healthcare
decisions outside of clinical trials.
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The effectiveness and safety of healthcare interventions
is best determined through randomised controlled trials
[1, 2]. However, major barriers to the successful conduct
and outcome of clinical trials are levels of recruitment
and retention. In the UK, only a small proportion of trials
actually recruit successfully to time and target [3–6].
Furthermore, in practice, it remains relatively uncommon
for a patient to participate in a clinical trial despite the de-
velopment of National Health Service organisational
structures that facilitate the integration of clinical research
and patient care [7], for example, the Clinical Research
Networks. Inadequate recruitment or retention have
implications not only for conclusive results but also exter-
nal validity and generalisability of the trial findings [8].
There is now international recognition of the import-
ance of paediatric clinical trials to inform healthcare
decisions for children and adolescents [9–12]. High
quality trials involving children are essential to ensure
that medication and treatments used in children are
effective and safe [9, 11, 12]. The lack of successful clin-
ical trials leads to many healthcare decisions for children
and adolescents being made with inadequate evidence,
including evidence extrapolated from trials involving
adults [12]. Only 6% of recently registered clinical trials
in the UK involved children [7]. The publication rate of
trials in adults has almost doubled over a 20-year period,
a rate increase that is around six times higher than for
paediatric trials over the same period [13]. In the past,
this low rate of paediatric trials was thought to be
mainly due to a concern for the vulnerability of children
leading to a reluctance by clinicians to undertake clinical
trials with young children [7, 14]. Nevertheless, high
rates of patient or parent refusal have also been identi-
fied as a key barrier for successful completion of these tri-
als [15], although a recent study has shown lower refusal
rates for paediatric trials involving therapeutic drugs [16].
A potential barrier to recruitment and retention is
the information provided to potential trial participants
[2, 17, 18]. How children and parents make decisions
regarding participation in research and what informa-
tion is important to them remain areas of uncertainty
[17, 19, 20]. Conventionally, participant information
about a trial is provided in printed form. These documents
should be understandable to potential trial participants
and assist their decision-making [21]. However, the format
of this information has received recurrent criticism, not-
ably for being too long, difficult and technical [22–25].
Furthermore, the content of trial sheets is mostly guided
by regulatory agencies and can be inconsistent with what
patients want to know [17, 22, 26]. A number of studies
report that trial participants do not understand informa-
tion contained within participant information sheets
(PISs) [27, 28] and that the information can be very wordyand overwhelming [22, 29]. Potential participants who
have lower levels of literacy are most likely to be affected
by this [30]. Furthermore, good graphic design, such as a
structure that aids navigation of the information and
visual appeal to invite and engage the reader, is often
lacking in PISs. For example, written information should
inform a decision about participation, but may act more
as a prospectus for the trial and as a contract between
researchers and the participant [31]. Re-writing, re-
designing and user-testing of trial information can produce
an understandable and preferred resource [32–34].
An alternative for providing information to potential
trial participants is through the use of a multimedia
information (MMI) resource [30, 35, 36], which presents
key information using a combination of video, anima-
tion, text and audio through a website. However,
research is needed to identify and evaluate different ways
of presenting MMI about research to children and par-
ents [22]. Multimedia presentation can be understood
through reading, listening and watching, and allows
people with different preferences to use the resource
effectively [30]. MMI resources can contain all key infor-
mation that would be found in a written participant in-
formation about the trial but focusing on information
deemed important for children, adolescents and their
parents [17, 35] when deciding whether to participate in
a trial. Furthermore, MMI resources can enable the pa-
tient to select the order in which they access the infor-
mation and allows people with different preferences to
use the resource more effectively. Finally people’s famil-
iarity with websites and the frequency of their use means
that MMI presented on a computer (or smartphone)
may now be used intuitively and easily by most people.
In educational settings, it has been estimated that indi-
viduals will remember approximately 10% of what they
read, 20% of what is heard, 30% if they can visualise and
hear the information, and 50% if they observe someone
doing something with an explanation [37]. Multimedia,
which involves using more than one medium of expres-
sion or communication, has been shown to be at least as
effective as printed information [38] and often more
effective in informing people [39–41]. MMI about med-
ical procedures can improve patient knowledge [42, 43],
but some have had variable impact on participant under-
standing [44]. However, a recent trial of children and
adolescents undergoing endoscopy showed that presen-
tation of information in electronic format produced
more certain consent decisions, compared to printed
information [45]. There is limited information about the
effect of MMI for patients on trial recruitment rates
[35, 36], although a relevant study is underway examin-
ing the use of MMI in trials recruiting adults in the UK
[46, 47]. Furthermore, studies using multimedia to
improve children’s understanding of clinical trials have
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with those using traditional paper-based information
[28]. There are a number of paediatric studies, particu-
larly in the United States, using video for informed con-
sent within a website format; however, the structure of
this information presentation is restrictive, requiring
users to view the video from start to finish [48].
MMI resources have the potential to inform and
engage potential trial participants in ways that printed
information can struggle to do (see Fig. 1 for possible
effectiveness pathway).
The TRECA (TRials Engagement in Children and
Adolescents) study will develop two MMI resources
through the use of participatory design involving individ-
ual and focus group interviews with children and adoles-
cents with long-term health conditions and their parents
(Table 1) [49]. This will ensure that the MMI resourcesFig. 1 Possible pathway of effectiveness of multimedia information (MMI) rare developed to meet the needs and preferences of
potential end users. The study will examine whether
providing key information about clinical trials through
the use of MMI resources increases recruitment and
retention and enables better decision-making of children
and adolescents participating in trials in the UK.Methods/Design
Aims
The aims of TRECA are to evaluate the potential for MMI
resources to improve the quality of decision-making about
participation in healthcare trials involving children and
adolescents with long-term health conditions, and to
assess the impact of MMI resources on trial recruitment
and retention and the quality of decision-making.
The objectives of the TRECA study are:esources
Table 1 Long-term health conditions
Long-term health conditions cover a wide range of conditions, that can
be life-long, slowly deteriorating, potentially curable and with a variable
course [49]. These conditions include (list not exhaustive):
• Diabetes
• Asthma
• Juvenile arthritis
• Cancer
• Cystic fibrosis
• Muscular dystrophy
• Early manifestation of a condition that may become chronic
(e.g. acne)
Conditions which would not be included in this definition of long-term
health conditions are vaccinations and those which are treated as
emergency or acute conditions
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health conditions, their parents and trial researchers
and clinicians, in the development of two MMI
resources for use when children and adolescents are
being asked to consider participation in a healthcare
trial.
 To obtain and analyse qualitative data from focus
groups with members of key stakeholder groups
(i.e. children and adolescents with long-term health
conditions, parents, clinicians, trial managers) to
ensure that the content and format of the MMI
resources reflect their needs and preferences.
 To user-test the MMI resources with children and
adolescents (and parents) to test their ability to
inform potential users.
 To evaluate the MMI resources in a series of trials
embedded within host trials in the UK, testing their
effect on recruitment and retention rates and
decision-making by comparing the effect of providing
standard written participant information with
provision of the MMI resource either in addition to
the standard written participant information or the
provision of the MMI resource alone.
Design overview
The study is divided into two phases, namely Phase one
(development) and Phase two (evaluation). The study
design is shown in Fig. 2. The development phase (Phase
one) involves qualitative methods followed by user testing,
aiming to produce two MMI resources (refer to Fig. 3 for
development stages of the MMI resources), with generic
elements relevant to any trial involving children and ado-
lescents and a template for the addition of specific content
for individual host healthcare trials. In the evaluation
phase (Phase two), the two MMI resources will be tested
in a series of embedded trials hosted within healthcare
trials (refer to Fig. 4 for the Phase two study design),following the addition of a small amount of host trial-
specific content to the MMI resource. The MMI resources
will be tested for their impact on decisions about trial par-
ticipation taken by children and adolescents and/or par-
ents and behaviours (rates of recruitment to, and
retention in, the host trials). The SPIRIT checklist describ-
ing the protocol is available as Additional file 1.
Phase one: development
MMI resource development
Two MMI resources will be developed (Fig. 3) to be
tested as an adjunct to, or replacement for, printed writ-
ten PISs for potential child and adolescent trial partici-
pants, and their parents. The overall goal is that young
potential participants and their parents will use the
MMI resources to inform their decisions about entry
and ongoing participation in the host trials. Both MMI
resources will have generic trial information (e.g. on ran-
domisation, study withdrawal, confidentiality, altruism
and personal benefit) and a section for trial-specific in-
formation (e.g. trial purpose, intervention, number of ap-
pointments and length). The MMI resources are
designed to be used by children, adolescents and their
parents to assist them with making an informed decision
about whether to participate in a trial.
The MMI resources will be commissioned from a spe-
cialist commercial supplier, so that their appearance and
functions are professional, sophisticated and contempor-
ary. One of the MMI resources will be intended for use
by children and their parents, and the other by adoles-
cents and their parents. Learning from a previous study
looking at the development of MMI resources for adults
deciding whether to participate in healthcare trials will
be incorporated into the design of the current MMI
resources [47, 50]. The distinct content and format of
the two MMI resources will be informed by the qualitative
study. The qualitative and user-testing data will also
inform the topics included in each MMI resource, and the
mixture of media (text, animation, video and info-
graphics). We will also explore the potential for the MMI
resources to be interactive, for example, allowing children
and adolescents to post questions to the host trial research
team and take mini-quizzes.
Participatory design: qualitative study to identify the
information needs and preferences of potential users of
MMI resources
Individual and focus group interviews will be undertaken
with (1) children and adolescents (aged 9–11, 12–14 and
15–17 years) with long-term health conditions (Table 1);
(2) parents of children and adolescents with long-term
health conditions; and (3) researchers and clinicians who
have experience with working in children’s clinical trials.
Sampling will be purposive and will aim to achieve
Fig. 2 TRECA study design. MMI multimedia information
Martin-Kerry et al. Trials  (2017) 18:265 Page 5 of 12variation with regard to age, sex, long-term health condi-
tion, trial experience, ethnicity, and sociodemographics of
participants. We plan to interview 6–10 people from each
participant group, although we will increase the number as
required until new data cease contributing to the analysis.
For the clinician and researcher focus groups we will sam-
ple to ensure a range of roles are represented. The age split
for children and adolescents is based approximately on
children’s likely capacity for a role in assent/consent deci-
sions, using an established three-part categorisation [51].
Participants will be recruited through a number of
mechanisms, including Alder Hey Children’s Hospital,
Generation R Young People Advisory Groups (groups
with membership of children and adolescents who ad-
vise on the design of research that involves children and
adolescents in the National Health Service) and three pa-
tient interest groups: PORT (Paediatric Oncology Reference
Team), the Invisible Illness group and the UK Juvenile-
onset Systemic Lupus Erythematosus Study Group.Data will be collected during two rounds of individual
and focus group interviews held approximately 2–3
months apart. Focus groups are preferred because they
will enable discussion of ideas amongst participants,
although the wishes of those who would opt for individ-
ual interviews will be accommodated. The first round will
take place before the MMI resources have been designed
in order to inform their content, style and delivery. The
second round will take place after draft MMI resources
have been produced in order to explore participants’ views
on these and their suggestions for amendment.
Semi-structured individual and focus group interviews
will be topic guided and focus on (1) preferences for
information about research and (2) preferences for con-
tent, style and delivery of MMI resources. Participants
will be prompted to discuss items of information
adapted from a study [52] of adult trial participants’ in-
formation needs, and items of information identified
from a study of children and adolescents’ trial
Fig. 3 Development of the multimedia information (MMI) resources
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done, whether the child or adolescent has to take part or
not, whether the participant will benefit personally from
taking part, and who will know the child or adolescent is
taking part.
Participants will also be prompted about their prefer-
ences for how the MMI resource looks and functions as
informed by the website industry Webby Awards criteria
[54], including general needs and preferences for MMI
content, potential for interactivity (e.g. question posting,
quizzes) and how the information should be presented
(e.g. whether people should receive the printed informa-
tion sheet before or after the MMI resource).
A pilot focus group will comprise younger children (6–8
years old) and involve showing them the developed MMI re-
source to explore their perspectives on whether the MMI re-
source is easy for them to use and understand the
information provided.
Where possible, the two rounds of data collection will
include the same participants to facilitate respondent val-
idation of the ongoing analysis, with some replacement
for the second round, when required. Each focus group
will have between four and ten participants and be
approximately 90 minutes in duration. Where participantsprefer, they will be offered an individual interview either
face-to-face or via Skype.
All individual and focus group interviews will be
audio-recorded and transcribed verbatim.
Qualitative data analysis to inform the development of the
MMI resources
Analysis of qualitative data will be thematic and focus
on identifying what information is important for chil-
dren, adolescents and their parents when deciding to
participate in a trial and their thoughts on the design
aspects of the MMI resource. Line by line coding will be
undertaken to identify key themes within each tran-
script. Analysis will be led by one researcher with guid-
ance provided by a qualitative research expert (BY) with
regular meetings to discuss data interpretation. The
codes will be grouped into themes and organised using
NVivo version 10 software. Following the principles of
participatory design, the findings on the needs and pref-
erences of potential users will inform the development
of two prototype MMI resources. We will work with
patient and public involvement (PPI) members, seeking
their thoughts on how to apply the findings into the
development and the design of the MMI resources. The
Fig. 4 Phase two study design. MMI multimedia information; CRN Clinical Research Network
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data obtained in the individual and focus group inter-
views. Where the views of the different participant
groups (children/adolescents, parents and clinicians)
diverge markedly, we will focus on the needs and prefer-
ences of children and adolescents.
User testing
Once the two MMI resource prototypes have been de-
veloped, the MMI resources will undergo user testing.
We will adapt the method of user testing employed in
the development of printed information, including PISs
for trials [34]. This involves an iterative process with
changes being made to the MMI resource in response to
the data received. We anticipate having two rounds of
user testing, with changes made to the MMI resources,
as required, after the first round. User testing involvessmall participant samples to generate quantitative data,
in which data patterns are interpreted to identify any
problems with a piece of information that may be re-
sponsive to change. Participants will be observed using
the MMI resources and then participate in brief struc-
tured interviews about the MMI resources. This will in-
volve testing participants’ knowledge and understanding
of the information in the resources and asking them to
indicate where in the resource this information is lo-
cated. The generated quantitative data are indicative, not
definitive, and not analysed statistically. The emphasis is
on identifying aspects of the information resource that
might hinder understanding.
User testing sampling
Participants for the user testing will be recruited via a
number of primary and secondary schools in Yorkshire,
Martin-Kerry et al. Trials  (2017) 18:265 Page 8 of 12UK, and aim for a diverse sample of participants in
terms of ethnicity, socioeconomic status and levels of
academic ability, including some participants who have
English as a second language. Individuals who partici-
pated in the qualitative study will not be eligible for the
user testing, as user testing produces its most valid
results with participants who are not already familiar
with the intervention being tested [32].
We will use the conventional sampling method in user
testing, namely rounds of 20 participants [55]. In the
testing of the MMI resource intended for older children
and adolescents, the samples of 20 will comprise a mix
of parents, children and adolescents (aiming to achieve a
spread of ages across the 12–17 years range). For the
less complex MMI resource, rounds will comprise 10
parents and 10 younger children, aiming to achieve a
spread across ages 6–11 years, with parents and children
using the MMI resource together.
For each MMI resource, the two rounds of user testing
will use different participants, to remove any effect of
prior learning. We will ensure that the samples in the
two rounds have similar profiles in terms of age and sex,
to better indicate problems in the MMI resources re-
quiring change.User testing data analysis
The data derived from user testing interviews will be
analysed quantitatively, although data are indicative
(e.g. 80% cannot find a particular piece of information).
Each item on the questionnaire will derive the following
scoring criteria: finding (found, found with difficulty
(i.e. found but only after a set time, usually more than
3 minutes) or not found); understanding (understood,
understood with difficulty (i.e. understood but only after
question rewording or repetition) or not understood).Phase two: evaluation of MMI resources
Embedded trials of MMI resources within host clinical
trials – design
The effectiveness of the two MMI resources will be eval-
uated in a series of trials embedded within six host trials
in the UK (see Fig. 4 for Phase two design) that are
recruiting children and adolescents with long-term
health conditions, using methods we have developed
previously [47]. That is, participants in each host trial will
be allocated randomly to one of two or more different
intervention groups. The embedded trial (aka nested trial
or ‘trial within a trial’) will be run with potential partici-
pants in each host trial – these people will be allocated
randomly to receive either the MMI resource plus the
printed information, the MMI resource alone, or the
printed information alone, to evaluate their relative effects
on recruitment rates (and the secondary outcomes).The objective is to test the effects of the MMI resources
on cognition and behaviour. The primary outcome will be
whether rates of recruitment to the host trials are in-
creased. We will also test (1) whether individuals who see
the MMI resource(s) make a more informed decision
about trial participation (or not); (2) whether rates of
retention in the host clinical trials are increased; and (3)
whether individuals are more satisfied with the process of
consent or assent.
Recruitment of host trials will occur through the
National Institute for Health Research Clinical Research
Network, funding bodies and through investigator net-
works. In previous qualitative work [56], we have identi-
fied that, while trialists welcome the idea of embedding
trials of recruitment interventions in their studies, these
need to be compatible with the host trial design and not
impose an extra workload. In the embedded trials, allo-
cation to groups will be achieved by random number
generator. Particularly, in trials in which we use individual
randomisation to the MMI resources, it will be practicably
very difficult to achieve concealment of randomisation.
Trials will use individual or cluster randomisation. Masking
of the allocation at outcome measurement will not be
possible since patients cannot be masked to the infor-
mation format they will receive but, as they will be
unaware of the embedded information trial, a lack of
masking will not bias their responses or decisions.
Trial eligibility criteria
Trials will be eligible for inclusion in TRECA if they are
recruiting within the UK and involve testing an interven-
tion with children and adolescents who have a long-term
health condition. Within each embedded trial, participants
will be children and adolescents being asked to participate
in the host healthcare trial and/or their parents. This is
critical, as it means that the host trial and the embedded
trial have different sample sizes. For the host trial the
sample comprises those children and adolescents/parents
agreeing to participate; for the embedded trial of the MMI
resources the sample comprises those asked to participate.
In some trials, the number asked to participate is much
larger, often more than double the host trial sample size.
Eligible trials should ideally have a sufficient sample
size to detect a difference between groups in the embed-
ded trial; trials will be using only printed or video partici-
pant information materials as standard (i.e. not already
including an MMI resource), and will be recruiting at least
some children and adolescents who have the potential to
contribute to a decision about consent or assent to partici-
pation in the trial. Trials will not be included if they are
only recruiting children too young to understand an MMI
resource (e.g. children aged under 5 years), or only chil-
dren with intellectual impairment such that understanding
or use of the MMI resource is not possible.
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respect to the long-term health condition (using PRISM
study criteria), the age of children and adolescents being
recruited into the trial, host trials unit, the type of inter-
vention (e.g. pharmaceutical, physical therapy, psycho-
logical), and the way that the MMI resource will be
presented to patients (e.g. parent and child viewing to-
gether versus adolescent viewing separately to parent).
Method of embedding MMI into trials
Each of the embedded trials will use a three-arm design,
in which individuals will receive the standard written
trial PIS alone, the standard PIS in addition to the MMI
resource, or the MMI resource alone (Fig. 2). We will
consider making the written PIS available via the MMI
resource, for example, by a link within the MMI re-
source to read or print the PIS document. This would
have the advantage of being more efficient, allowing
people to access both the MMI resource and the PIS
via the computer. However, we will consider important
practical concerns such as text readability on screens
and participant preferences, and so will seek the opin-
ions of participants in the focus groups during the
development study phase. We will also measure the
number of page views and the frequency which individual
elements of the MMI resource are viewed.
Patients allocated to the control arm of the embedded
trial will be given the printed PIS only (as is usual).
Those allocated to one of the intervention arms will
receive either the MMI resource alone or the printed
PIS and the MMI resource(s). We will not determine the
order in which participants access the PIS and MMI
resource (for those participants who receive both) and
will leave this for the host trial to determine, to suit the
practical demands of patient recruitment. However, we
will ask the host trial to record the order in which par-
ticipants are given and access the PIS/MMI resource,
and report this observation in the report of each embed-
ded trial. The MMI resources will be presented in the
clinic on a computer or dedicated tablet computer. Par-
ticipants will also be able to access the MMI resources
at home (via smartphone or a tablet or PC) via a link
that is emailed to them. In some circumstances, home
viewing will take place before the patient’s decision on
clinical trial participation has been taken. Some patients
will also want to be given access to the MMI resource
after they have decided to take part in the host health-
care trial, just as they would if they had been given
standard printed information only.
Outcome measures
The primary outcome will be the rates of recruitment to
each host trial. We will calculate the proportion of
patients who agree to participate from the total numberapproached, for each arm of the embedded trial. This
study is investigating whether MMI resources improve
the quality of decision-making, related to individuals
being more informed about the trial. Improved decision-
making may have no impact on trial recruitment rates,
although it is also possible that it could either increase
or decrease rates as a result of individuals being more
informed. It is therefore important that we also measure
secondary outcomes of retention in the trials, and qual-
ity of decision-making. We will measure retention by
obtaining data on the number and timing of drop outs
from each host trial. The quality of decision-making by
potential host trial participants will be measured through
the completion by children, adolescents and parents (as
relevant) of a decisional scale, adapted from one used
within the REFORM trial [57] and drawing conceptually
on the SURE [58] and DelibeRATE scales [59, 60]. We will
report study results in line with published guidelines [61].
Sampling considerations
The projected effect of the MMI resources will vary in
size according to the setting of the host trial, the back-
ground recruitment rate, and the intervention being
tested in the host trial. This makes it difficult to establish
a sample size calculation for each of the six embedded
trials. The effectiveness of the MMI resources is being
assessed against three outcome measures, namely host
trial recruitment rate, quality of decision-making on partici-
pation (or not) and host trial retention rate. Results from
each embedded trial will be combined in a prospective
meta-analysis for decision scores and recruitment rate data
from all six host trials participating in the TRECA study.
PPI
The Investigators and research team have a strong com-
mitment to PPI in the TRECA Study. TRECA has a
Patient and Parent Advisory Group which will play a key
role in reviewing and providing input into documenta-
tion used in the various stages of the study, including
topic guides and prototype MMI resources. The Patient
and Parent Advisory Group will also participate in the
piloting of user testing questionnaires to ensure that the
question wording and length are appropriate. Two mem-
bers of the Patient and Parent Advisory Group are also
members of the TRECA Study Advisory Group and one
or two PPI members will be involved in co-facilitation of
the second set of focus groups.
Discussion
Whilst trials have been undertaken for many decades in
medicine, limited data is available about the decision-
making processes for trial participants and which infor-
mation is important for them when considering whether
to participate [2, 21, 52]. Studies that have examined the
Martin-Kerry et al. Trials  (2017) 18:265 Page 10 of 12information needed for potential participants to make
such decisions often do not include the level of detail
that participants wanted to receive [52]. The numbers of
studies looking at this issue in relation to children, ado-
lescents and their parents, is limited [19, 20, 22, 53].
The TRECA study will identify the information that
children and adolescents consider to be most important
when deciding whether or not to participate in clinical
trials. Informed by the principles of participatory design,
we will produce MMI resources that aim to meet
children, adolescents and their parents’ needs and pref-
erences for information content and presentation. In
particular, this should lead to improved patient informa-
tion resources that offer relevant information in a way
that is accessible to all potential participants, whilst also
increasing their understanding of clinical trials in gen-
eral. Ultimately, it is anticipated that improving partici-
pant information resources will increase participation in
clinical trials. Specifically, this study will lead to the
development of two MMI resources that are suitable for
children and adolescents invited to future clinical trials.
The findings may also be of use to researchers in differ-
ent settings, such as education or mental health, in order
to better inform and recruit participants to studies. It
may also identify principles that are transferable to other
medical settings where providing accessible information
is crucial, for example, regarding patient decisions about
hospital procedures or treatment options.
Results from the TRECA study will be published in
peer-reviewed journals and disseminated widely through
conferences and events. Where possible, we will also use
social media to publicise the findings. In particular, we
will aim to engage with health charities, self-help groups
and lobbyists, with a view to informing children and
adolescents with a variety of long-term health conditions
who may be involved in research.
Trial status
Phase one of the study has commenced. Recruitment for
Phase two has not yet commenced.
Additional file
Additional file 1: Standard Protocol Items Recommendations for
Interventional Trials (SPIRIT) 2013 checklist. (DOC 122 kb)
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